NHS to Share Patient Data with Third Parties, Fueling Privacy and Security Fears
The
Financial Times revealed that NHS Digital, which runs the health service’s IT systems, will create a database containing the medical records of around 55 million patients in England who are registered with a GP clinic. This includes sensitive data on mental and sexual health, criminal records and abuse.
This information will subsequently be made available to academic and commercial third parties involved in research and planning, although no details on the types of organizations that will have access have been provided.
The initiative follows suggestions that the UK’s response to the COVID-19 pandemic was hampered by lack of data sharing and access, including in a report published this year by the House of Commons Science and Technology Committee.
William Bill Shakespeare dies of stroke unrelated to landmark Pfizer COVID vaccine - 26-May-2021
nzcity.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nzcity.co.nz Daily Mail and Mail on Sunday newspapers.
William Bill Shakespeare dies of stroke unrelated to landmark Pfizer COVID vaccine - 26-May-2021
nzcity.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nzcity.co.nz Daily Mail and Mail on Sunday newspapers.
UK Health Secretary Matt Hancock said he is increasingly confident that England is on track for the government s roadmap to exit the coronavirus lockdown, local media reported. His remarks came after a study by Public Health England (PHE) showed promising results for the two main vaccines being used to fight the pandemic in Britain, reports Xinhua news agency. I m increasingly confident we re on track for the roadmap because this data shows the vaccine after two doses works just as effectively, and we all know that the vaccine is our way out of this, Hancock told Sky News on Sunday. According to the PHE study, which took place between April 5 and May 16, the Pfizer vaccine was 88 per cent effective against symptomatic disease from the India-related variant two weeks after the second dose, compared with 93 per cent effectiveness against the variant identified in Kent.